FDA 483 - Innovative Med Inc. - April 15, 2025

An FDA inspection of IMI Group dba Innovative Med Inc., a manufacturer in Irvine, CA, revealed one repeat observation. The firm's internal audit procedure was not followed, as a regulatory consultant audited areas for which she had direct responsibility. This indicates a lack of independence in the quality audit process.